Press Release

Viral Safety Expert, Audrey Brussel, joins PathoQuest
Viral Safety Expert, Audrey Brussel, joins PathoQuest

PathoQuest announces the appointment of Audrey Brussel, Ph.D. to the newly created position of Viral Safety Leader. Her addition to the company will strengthen PathoQuest’s in-house expertise in viral safety. Her insights and knowledge of the pharmaceutical industry from a customer’s perspective will help deliver a better service and support the growth of the company’s rapidly expanding quality control testing business for biologics.

read more
COVID-19: PathoQuest services continuity update
COVID-19: PathoQuest services continuity update

PathoQuest laboratory activities will not be disturbed, some of our support activities will be performed remotely when possible but our offices and labs remain open and our team is ready to work with you on new projects.

read more
PathoQuest’s Paris Based Facility Obtains GLP Conformity Certificate for its Biologics Genomic Testing Services Based on Next-Generation Sequencing Technology
PathoQuest’s Paris Based Facility Obtains GLP Conformity Certificate for its Biologics Genomic Testing Services Based on Next-Generation Sequencing Technology

PathoQuest, announced that it has received GLP certificate of conformity following a successful inspection by the French National Agency for Medicine and Health Products Safety (ANSM). PathoQuest is the first company in France to receive such a certificate from the ANSM for NGS viral safety testing. (“high-throughput sequencing detection of incidental replicative virus test in eukaryote cells”).

read more

Click here to learn more about PathoQuest’s Biologics Genomic Service for biopharmaceutical companies.

Connect